Prevention of nosocomial infections in the neonatal intensive care unit

Current Opinion in Pediatrics

Volumn 14, Issue 2, 2002, Pages 157-164

  Adams Chapman, Ira ^a   Stoll, Barbara J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BENZOIN; CHLORHEXIDINE; EMOLLIENT AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; IMMUNOGLOBULIN; METICILLIN; MINOCYCLINE; PALIVIZUMAB; POVIDONE IODINE; RIFAMPICIN; SULFADIAZINE SILVER; VANCOMYCIN; XIPAMIDE;

CENTRAL VENOUS CATHETER; DIAGNOSTIC PROCEDURE; ENTERIC FEEDING; HAND WASHING; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RISK; INSTRUMENT STERILIZATION; INTRAVENOUS CATHETER; MONITORING; NEWBORN; NEWBORN INTENSIVE CARE; NURSERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN CARE;

ANTISEPSIS; BACTEREMIA; BLOOD SPECIMEN COLLECTION; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; HANDWASHING; HUMANS; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; RISK FACTORS; UNITED STATES;

EID: 0036120210     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200204000-00003     Document Type: Review

References (80)

1. Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network
2. Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit
3. Survival, morbidity, and resource use of infants of 25 weeks' gestational age or less
4. Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality
5. Improving survival of vulnerable infants increases neonatal intensive care unit nosocomial infection rate
6. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992-April 2000, issued June 2000
7. Semiannual report
8. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units
9. Neonatal nosocomial infections
10. Nosocomial infections among neonates in high-risk nurseries in the United States
11. Occurrence of nosocomial bloodstream infections in six neonatal intensive care units
12. Collaborative quality improvement for neonatal intensive care
13. Bacteremia, central catheters, and neonates: When to pull the line
14. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy
15. Bloodstream infections in neonatal intensive care unit patients: Results of a multicenter study
16. Dexamethasone therapy increases infection in very low birthweight infants
17. Risk factors for nosocomial infection in a high-risk nursery
18. Risk factors for nosocomial infections in critically ill newborns: A 5-year prospective cohort study
19. Patient density, nurse-to-patient ratio and nosocomial infection risk in a pediatric cardiac intensive care unit
20. The role of understaffing and over-crowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit
21. The role of understaffing in central venous catheter-associated bloodstream infections
22. Improving compliance with hand hygiene in hospitals
23. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit
24. Nosocomial infection update
25. Resistance patterns among nosocomial pathogens: Trends over the past few years
26. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: A challenge to hospital leadership
27. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
28. Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins
29. Rationing antibiotic use in neonatal units
30. Implementing practice guidelines for appropriate antimicrobial usage
31. CDC definitions for nosocomial infections, 1988
32. Quantitative blood cultures in the diagnosis of sepsis in infants with umbilical and Broviac catheters
33. Guidelines for the management of intravascular catheter-related infections
34. Guideline for prevention of intravascular device-related infections, I: Intravascular device-related infections: An overview
35. The necessity of routinely replacing peripheral intravenous catheters in hospitalized children
36. Catheter manipulations and the risk of catheter-associated bloodstream infection in neonatal intensive care unit patients
37. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates
38. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: A randomized, controlled trial
39. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection
40. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and blood stream infections: A randomized, double-blind trial
41. Intravascular catheter-related sepsis-novel methods of prevention
42. Antimicrobial-coated/bonded and impregnated intravascular catheters
43. Prevention of nosocomial bloodstream infections: Effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters
44. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections
45. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children
46. Skin hygiene and infection prevention: More of the same or different approaches?
47. Effect of hand cleansing with antimicrobial soap or alcohol-based gel on microbial colonization of artificial fingernails worn by health care workers
48. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit
49. Neonatal skin care
50. APIC guideline for handwashing and hand antisepsis in health care settings
51. CDC guidelines for the prevention and control of nosocomial infections: Guideline for handwashing and hospital environmental control, 1985
52. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: A prospective trial
53. Prospective randomized, investigator-masked trial of a novel chlorhexidine-impregnated disk (Biopatch) on central venous and arterial catheters: Program and abstracts of the Fourth International Decennial Conference on Nosocomial and Healthcare-Associated Infections
54. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates
55. Skin care management practices for premature infants
56. A survey of skin care practices for premature low birth weight infants
57. Adhesives and emollients in the preterm infant
58. Characterization of vernix caseosa as a natural biofilm: Comparison to standard oil-based ointments
59. Characterization of vernix caseosa: Water content, morphology, and elemental analysis
60. An outbreak of Serratia marcescens in two neonatal intensive care units
61. Enterobacter cloacae outbreak in the NICU related to disinfected thermometers
62. Disinfectant contaminated with Klebsiella oxytoca as a source of sepsis in babies
63. Ventilator-associated pneumonia in very low-birth-weight infants at the time of nosocomial bloodstream infection and during airway colonization with Pseudomonas aeruginosa
64. Failure of systemic antibiotics to eradicate gram-negative bacilli from the airway of mechanically ventilated very low-birth-weight infants
65. Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions
66. Nosocomial respiratory syncytial virus infections: The "cold war" has not ended
67. Nesecemial respiratory syncytial virus infections in children's wards
68. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus
69. Prevention of nosocomial transmission of respiratory syncytial virus in a newborn nursery
70. Reducing the rate of nosocomially transmitted respiratory syncytial virus
71. Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV
72. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion
73. The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit
74. Intravenous immunoglobulin for preventing infection in preterm and/or low-birthweight infants
75. Promising stratagems for reducing the burden of neonatal sepsis
76. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates
77. G-CSF and GM-CSF for treating or preventing neonatal infections